Literature DB >> 19837294

Vaccines for Venezuelan equine encephalitis.

Slobodan Paessler1, Scott C Weaver.   

Abstract

Arboviruses are capable of causing encephalitis in animals and human population when transmitted by the vector or potentially via infectious aerosol. Recent re-emergence of Venezuelan equine encephalitis virus (VEEV) in South America emphasizes the importance of this pathogen to public health and veterinary medicine. Despite its importance no antivirals or vaccines against VEEV are currently available in the USA. Here we review some of the older and newer approaches aimed at generating a safe and immunogenic vaccine as well as most recent data about the mechanistic of protection in animal models of infection.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19837294      PMCID： PMC2764542          DOI： 10.1016/j.vaccine.2009.07.095

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  72 in total

1.  Venezuelan equine encephalomyelitis due to vaccination in man.

Authors:  L S SUTTON; C C BROOKE
Journal:  J Am Med Assoc       Date:  1954-08-21

2.  THE CAUSATIVE AGENT OF INFECTIOUS EQUINE ENCEPHALOMYELITIS IN VENEZUELA.

Authors:  V Kubes; F A Ríos
Journal:  Science       Date:  1939-07-07       Impact factor: 47.728

Review 3.  How do cytotoxic lymphocytes kill their targets?

Authors:  S Shresta; C T Pham; D A Thomas; T A Graubert; T J Ley
Journal:  Curr Opin Immunol       Date:  1998-10       Impact factor: 7.486

4.  Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA.

Authors:  I Frolov; E Frolova; S Schlesinger
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Venezuelan equine encephalomyelitis in an adult animal host. An electron microscopic study.

Authors:  L Gorelkin
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

6.  Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.

Authors:  M J Turell; G V Ludwig; J Kondig; J F Smith
Journal:  Am J Trop Med Hyg       Date:  1999-06       Impact factor: 2.345

7.  Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus.

Authors:  R J Phillpotts; L D Jones; S C Howard
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

Review 8.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

9.  Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.

Authors:  F B Grieder; N L Davis; J F Aronson; P C Charles; D C Sellon; K Suzuki; R E Johnston
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

10.  Recombinant alphaviruses are safe and useful serological diagnostic tools.

Authors:  Haolin Ni; Nadezhda E Yun; Michele A Zacks; Scott C Weaver; Robert B Tesh; Amelia P Travassos da Rosa; Ann M Powers; Ilya Frolov; Slobodan Paessler
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345
View more
  42 in total

Review 1.  DNA-launched live-attenuated vaccines for biodefense applications.

Authors:  Peter Pushko; Igor S Lukashevich; Scott C Weaver; Irina Tretyakova
Journal:  Expert Rev Vaccines       Date:  2016-04-25       Impact factor: 5.217

2.  Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus.

Authors:  Elena K Gaidamakova; Ian A Myles; Dennis P McDaniel; Sandip K Datta; Michael J Daly; Cedar J Fowler; Patricia A Valdez; Shruti Naik; Manoshi Gayen; Paridhi Gupta; Anuj Sharma; Pamela J Glass; Radha K Maheshwari
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

3.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

4.  Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Authors:  Joseph A Kendra; Cynthia de la Fuente; Ashwini Brahms; Caitlin Woodson; Todd M Bell; Bin Chen; Yousuf A Khan; Jonathan L Jacobs; Kylene Kehn-Hall; Jonathan D Dinman
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

5.  Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella.

Authors:  Patricia V Aguilar; Jose G Estrada-Franco; Roberto Navarro-Lopez; Cristina Ferro; Andrew D Haddow; Scott C Weaver
Journal:  Future Virol       Date:  2011       Impact factor: 1.831

6.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

7.  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.

Authors:  Irina Tretyakova; Igor S Lukashevich; Pamela Glass; Eryu Wang; Scott Weaver; Peter Pushko
Journal:  Vaccine       Date:  2012-12-31       Impact factor: 3.641

8.  IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.

Authors:  Shannan L Rossi; Mathilde Guerbois; Rodion Gorchakov; Kenneth S Plante; Naomi L Forrester; Scott C Weaver
Journal:  Virology       Date:  2013-01-22       Impact factor: 3.616

Review 9.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Authors:  Yun Young Go; Udeni B R Balasuriya; Chong-Kyo Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

10.  Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.

Authors:  Brian D Carey; Tatiana Ammosova; Chelsea Pinkham; Xionghao Lin; Weidong Zhou; Lance A Liotta; Sergei Nekhai; Kylene Kehn-Hall
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.